2023 Endocrine Case Management: Meet the Professor

الوصف

2023 Endocrine Case Management: Meet the Professor – Original PDF

ENDO 2023
CONTENTS
ADIPOSE TISSUE, APPETITE, OBESITY, AND LIPIDS
Weight Recurrence After Bariatric Surgery 2
Jaime Almandoz, MD, MBA
Evaluation and Management of Nonalcoholic Fatty Liver Disease in Adults 8
Avin Pothuloori, MD
How to Diagnose Underlying Causes and Contributing Factors in Obesity 16
Elisabeth F. C. van Rossum, MD, PhD, and Mariëtte R. Boon, MD, PhD
ADRENAL
Management of Adrenocortical Carcinoma 26
Gary D. Hammer, MD, PhD, Matthew A. Nehs, MD, and Gerard M. Doherty, MD
Pearls and Myths in the Evaluation and Management of Pheochromocytoma 38
Karel Pacak, MD, PhD, DSc
Primary Aldosteronism: When and How to Test for It? 50
Adina F. Turcu, MD, MS
Bilateral Adrenal Masses: Evaluation and Management 57
Stylianos Tsagarakis, MD, PhD
How Do I Workup a Woman With Androgen Excess? 66
Corrine Welt, MD
Adrenal Incidentalomas: Contemporary Evaluation and Management 74
William F. Young, Jr, MD, MSc
BONE AND MINERAL METABOLISM
Diseases Associated With the Extracellular Calcium-Sensing Receptor 84
Michael Mannstadt, MD
Hypoparathyroidism: Case Management 90
Dolores Shoback, MD
Management of Bone Health in Breast Cancer Survivors
CARDIOVASCULAR ENDOCRINOLOGY
Dyslipidemia in Thyroid Diseases, Cushing Syndrome, and Long-Term
Glucocorticoid Use 106
Connie B. Newman, MD
Lipid Management in Patients With Diabetes Mellitus 117
Lisa R. Tannock, MD
Evidence-Based, Practical Approach to Primary Aldosteronism 123
Jun Yang, MBBS, PhD
DIABETES MELLITUS AND GLUCOSE METABOLISM
An Evidence-Based Medication Algorithm for Type 2 Diabetes Mellitus 132
Howard B. A. Baum, MD
Management of Untoward Metabolic Effects of Psychotropic Medications 138
Susanne U. Miedlich, MD
Challenges in the Diagnosis and Management of Hypoglycemia 147
Mary Elizabeth Patti, MD
Effective Use of Telehealth in Outpatient Endocrine Care 160
Varsha Vimalananda, MD, MPH, and Stephanie Crossen, MD, MPH
What to Do When Patients With Diabetes Have Suboptimal Glycemic Control 168
Carol H. Wysham, MD
NEUROENDOCRINOLOGY AND PITUITARY
Tumors of the Posterior Pituitary 188
Michael Buchfelder, MD, PhD
Gastroenteropancreatic Neuroendocrine Neoplasms for Endocrinologists 195
Wouter W. de Herder, MD, PhD
Prolactinoma: When Medical Treatment Fails………………………………..202
Niki Karavitaki, MSc, PhD
Management of Challenging Cases of Immune Checkpoint Inhibitor Hypophysitis 208
Kevin C. J. Yuen, MD
PEDIATRIC ENDOCRINOLOGY
Growth Hormone Treatment in Children Born Prematurely 216
Margaret Cristina da Silva Boguszewski, MD, PhD
Current Concepts in Delayed Puberty………………………………………221
Yee-Ming Chan, MD, PhD
Care of Preschool Children With Type 1 Diabetes Mellitus 230
Linda A. DiMeglio, MD, MPH
Disorders of Sex Development: Current Concepts and Challenges 237
David Zangen, MD
REPRODUCTIVE ENDOCRINOLOGY
Use of Laboratory Tests in Transgender Medicine 246
Caroline J. Davidge-Pitts, MB, BCh
Managing the Nonreproductive Comorbidities of Polycystic Ovary Syndrome 253
Andrea Dunaif, MD
Testosterone Replacement Therapy: Navigating the Pharmacologic Landscape 263
Frances J. Hayes, MB BCh BAO
Management of Functional Hypogonadism in Men 269
Michael S. Irwig, MD
Approach to Nonbinary Adolescents and Young Adults 277
Karine Khatchadourian, MD, MSc, and Daniel L. Metzger, MD
Fertility Preservation Considerations for Gender-Diverse Adolescents
and Young Adults 284
Leena Nahata, MD
Gender-Affirming Hormone Therapy: Beyond the Guidelines 291
Joshua D. Safer, MD
Long-Term Outcomes After Gender-Affirming Surgeries 298
Brielle Weinstein, MD, Rebecca B. Schechter, MD, and Loren S. Schechter, MD
THYROID
Long-Term Management of Patients With Low-Risk Thyroid Cancer 306
Megan R. Haymart, MD
Syndromes of Resistance to Thyroid Hormone 311
Carla Moran, MB PhD
Evaluation and Management of Subclinical Hyperthyroidism and Hypothyroidism 320
Douglas S. Ross, MD
Management of Pediatric Graves Disease 327
Christiaan F. Mooij, MD, PhD, and A. S. Paul van Trotsenburg, MD, PhD
TUMOR BIOLOGY
Radioligand Therapy for Endocrine-Related Cancers: Role of the Referring
Endocrinologist 336
Alan G. Harris, MD, PhD, and Richard A. Feelders, MD, PhD
Managing Medullary Thyroid Carcinoma in Patients With RET Pathogenic Variants 345
Ana Oliveira Hoff, MD
MISCELLANEOUS
“Hormone Optimization,” “Rejuvenation,” and What Men Read: Opportunity and
Threat to Evidence-Based Medicine 358
Bradley D. Anawalt, MD
Management of Androgen Abuse, Recovery, and Dependence 365
David J. Handelsman, AO, MBBS, PhD